Micafungin in Premature and Non-premature Infants


BACKGROUND Invasive fungal infections cause excessive morbidity and mortality in premature neonates and severely ill infants. METHODS Safety and efficacy outcomes of micafungin were compared between prematurely and non-prematurely born infants <2 years of age. Data were obtained from all completed phase I-III clinical trials with micafungin that had… (More)
DOI: 10.1097/INF.0000000000000434

10 Figures and Tables


  • Presentations referencing similar topics